BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33020213)

  • 1. Effect of CARD9 Deficiency on Neutrophil-Mediated Host Defense against Pulmonary Infection with Streptococcus pneumoniae.
    Ishizuka S; Yokoyama R; Sato K; Shiroma R; Nakahira A; Yamamoto H; Takano K; Kagesawa T; Miyasaka T; Kasamatsu J; Kanno E; Tanno H; Ishii K; Kawakami K
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33020213
    [No Abstract]   [Full Text] [Related]  

  • 2. Dectin-2-dependent host defense in mice infected with serotype 3 Streptococcus pneumoniae.
    Akahori Y; Miyasaka T; Toyama M; Matsumoto I; Miyahara A; Zong T; Ishii K; Kinjo Y; Miyazaki Y; Saijo S; Iwakura Y; Kawakami K
    BMC Immunol; 2016 Jan; 17():1. PubMed ID: 26727976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role for CARD9 in pneumocystis pneumonia host defence.
    Kottom TJ; Nandakumar V; Hebrink DM; Carmona EM; Limper AH
    Cell Microbiol; 2020 Oct; 22(10):e13235. PubMed ID: 32548948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma.
    Yamamoto N; Kawakami K; Kinjo Y; Miyagi K; Kinjo T; Uezu K; Nakasone C; Nakamatsu M; Saito A
    Microbes Infect; 2004 Nov; 6(14):1241-9. PubMed ID: 15555529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection.
    José RJ; Williams AE; Mercer PF; Sulikowski MG; Brown JS; Chambers RC
    J Immunol; 2015 Jun; 194(12):6024-34. PubMed ID: 25948816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with Cryptococcus neoformans.
    Yamamoto H; Nakamura Y; Sato K; Takahashi Y; Nomura T; Miyasaka T; Ishii K; Hara H; Yamamoto N; Kanno E; Iwakura Y; Kawakami K
    Infect Immun; 2014 Apr; 82(4):1606-15. PubMed ID: 24470469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection.
    Herbold W; Maus R; Hahn I; Ding N; Srivastava M; Christman JW; Mack M; Reutershan J; Briles DE; Paton JC; Winter C; Welte T; Maus UA
    Infect Immun; 2010 Jun; 78(6):2620-30. PubMed ID: 20368349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
    Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia.
    Hommes TJ; Hoogendijk AJ; Dessing MC; Van't Veer C; Florquin S; Colonna M; de Vos AF; van der Poll T
    J Pathol; 2014 Aug; 233(4):357-67. PubMed ID: 24752755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of gamma/delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection.
    Nakasone C; Yamamoto N; Nakamatsu M; Kinjo T; Miyagi K; Uezu K; Nakamura K; Higa F; Ishikawa H; O'brien RL; Ikuta K; Kaku M; Fujita J; Kawakami K
    Microbes Infect; 2007 Mar; 9(3):251-8. PubMed ID: 17306586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential use of CARD9 by dectin-1 in macrophages and dendritic cells.
    Goodridge HS; Shimada T; Wolf AJ; Hsu YM; Becker CA; Lin X; Underhill DM
    J Immunol; 2009 Jan; 182(2):1146-54. PubMed ID: 19124758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia.
    Hommes TJ; van Lieshout MH; van 't Veer C; Florquin S; Bootsma HJ; Hermans PW; de Vos AF; van der Poll T
    PLoS One; 2015; 10(12):e0145138. PubMed ID: 26673231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection.
    Sun K; Salmon SL; Lotz SA; Metzger DW
    Infect Immun; 2007 Mar; 75(3):1196-202. PubMed ID: 17210665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-type Lectin Mincle Recognizes Glucosyl-diacylglycerol of Streptococcus pneumoniae and Plays a Protective Role in Pneumococcal Pneumonia.
    Behler-Janbeck F; Takano T; Maus R; Stolper J; Jonigk D; Tort Tarrés M; Fuehner T; Prasse A; Welte T; Timmer MS; Stocker BL; Nakanishi Y; Miyamoto T; Yamasaki S; Maus UA
    PLoS Pathog; 2016 Dec; 12(12):e1006038. PubMed ID: 27923071
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yamaguchi M; Hirose Y; Takemura M; Ono M; Sumitomo T; Nakata M; Terao Y; Kawabata S
    Front Cell Infect Microbiol; 2019; 9():301. PubMed ID: 31482074
    [No Abstract]   [Full Text] [Related]  

  • 16. Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism.
    Whibley N; Jaycox JR; Reid D; Garg AV; Taylor JA; Clancy CJ; Nguyen MH; Biswas PS; McGeachy MJ; Brown GD; Gaffen SL
    J Immunol; 2015 Oct; 195(8):3781-92. PubMed ID: 26336150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia.
    Machado MG; Tavares LP; Souza GVS; Queiroz-Junior CM; Ascenção FR; Lopes ME; Garcia CC; Menezes GB; Perretti M; Russo RC; Teixeira MM; Sousa LP
    FASEB J; 2020 Feb; 34(2):2749-2764. PubMed ID: 31908042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia.
    Marriott HM; Hellewell PG; Cross SS; Ince PG; Whyte MK; Dockrell DH
    J Immunol; 2006 Nov; 177(9):6480-8. PubMed ID: 17056580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.
    Weber S; Tian H; van Rooijen N; Pirofski LA
    Infect Immun; 2012 Apr; 80(4):1314-22. PubMed ID: 22290146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.
    Steinwede K; Henken S; Bohling J; Maus R; Ueberberg B; Brumshagen C; Brincks EL; Griffith TS; Welte T; Maus UA
    J Exp Med; 2012 Oct; 209(11):1937-52. PubMed ID: 23071253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.